Rapid Reduction in Breast Cancer Mortality With Inorganic Arsenic in Drinking Water
Author(s) -
Allan H. Smith,
Guillermo Marshall,
Yan Yuan,
Craig Steinmaus,
Jane Liaw,
Martyn T. Smith,
Lily Wood,
Marissa Heirich,
Rebecca Fritzemeier,
Mark D. Pegram,
Catterina Ferreccio
Publication year - 2014
Publication title -
ebiomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.596
H-Index - 63
ISSN - 2352-3964
DOI - 10.1016/j.ebiom.2014.10.005
Subject(s) - arsenic trioxide , arsenic , breast cancer , medicine , cancer , mortality rate , acute promyelocytic leukemia , oncology , physiology , cancer research , chemistry , biochemistry , retinoic acid , organic chemistry , gene
Arsenic trioxide is effective in treating promyelocytic leukemia, and laboratory studies demonstrate that arsenic trioxide causes apoptosis of human breast cancer cells. Region II in northern Chile experienced very high concentrations of inorganic arsenic in drinking water, especially in the main city Antofagasta from 1958 until an arsenic removal plant was installed in 1970.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom